...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Gasoline

,,,hahahhaha,,,,,I like the way you think tada,,,,, :o) ,,,,, I am optimistic,,,,however we need some good business sense from RVX management to take place here so that they dont throw the baby out with the bath water..........jmo

Share
New Message
Please login to post a reply